First Look Analysts Research Calls for Monday, March 6; Goldman Starts Apple with a Buy
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Meritage (MTH) upgraded to Overweight from Neutral at JP Morgan; tgt $129 > Vir Biotechnology (VIR) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $34 Downgrades:…
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Meritage (MTH) upgraded to Overweight from Neutral at JP Morgan; tgt $129
> Vir Biotechnology (VIR) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $34
Downgrades:
> Allbirds (BIRD) downgraded to Neutral from Outperform at Wedbush; tgt $3
> KB Home (KBH) downgraded to Underweight from Overweight at JP Morgan; tgt lowered to $32.50
> Silvergate Capital (SI) downgraded to Underperform from Neutral at Wedbush; tgt lowered to $4
> Wendy’s (WEN) downgraded to Neutral from Buy at Northcoast
Others:
> Apple (AAPL) initiated with a Buy at Goldman; tgt $199
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.